Provectus Biopharmaceuticals Highlights Preclinical Evidence of PV-10-Mediated Immune Modulation in Burn Wound Healing; Porcine Study Demonstrates Shift Toward Pro-Regenerative Tissue Environment
KNOXVILLE, Tenn., April 02, 2026 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus”…
Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies
January 25, 2026 17:30 ET | Source: AVITA Medical First surgeon-reported case…
$LIVEBEAR: The Chillest Bear on the Internet, Now Going Worldwide After the Recent Token Burn
Melbourne, Australia, Dec. 27, 2025 (GLOBE NEWSWIRE) -- $LIVEBEAR, a community driven…
Burn Blend Releases Comprehensive Gelatin Trick Recipe Based Protocol Guide in Response to Rising Public Interest in Weight-Management Methods
New York City, NY, Nov. 23, 2025 (GLOBE NEWSWIRE) -- The organization…
